
Functional Selectivity of G Protein-Coupled Receptor Ligands
Kim Neve
₹5,137

by Kim Neve
Free delivery. Nothing extra to pay at checkout.
As sites of action for drugs used to treat schizophrenia and Parkinson's disease, dopamine receptors are among the most validated drug targets for neuropsychiatric disorders. Dopamine receptors are also drug targets or potential targets for other disorders such as substance abuse, depression, Tourette's syndrome, and attention deficit hyperactivity disorder.
Description supplied by the publisher.